环球印务(002799) - 2022 Q1 - 季度财报(更正)

Financial Performance - The company's operating revenue for Q1 2022 was ¥539,587,507.41, a decrease of 20.29% compared to ¥676,970,746.02 in the same period last year[4]. - The net profit attributable to shareholders for Q1 2022 was ¥27,402,907.36, down 8.77% from ¥30,036,045.48 in the previous year[4]. - The basic earnings per share for Q1 2022 was ¥0.11, a decrease of 8.33% from ¥0.12 in the same period last year[5]. - The net profit for Q1 2022 was CNY 31,925,678.59, a decrease of 12.5% compared to CNY 36,354,428.69 in Q1 2021[23]. - The operating profit for Q1 2022 was CNY 35,695,830.95, down from CNY 42,192,555.84 in the same period last year, reflecting a decline of 15.5%[23]. - The total comprehensive income for Q1 2022 was CNY 31,925,678.59, down from CNY 36,354,428.69 in the same period last year, reflecting a decrease of 12.5%[24]. Cash Flow and Liquidity - The net cash flow from operating activities improved significantly to ¥25,807,505.26, compared to a negative cash flow of ¥52,731,812.25 in the same period last year, representing a 148.94% increase[4]. - The total revenue from sales and services received in cash was CNY 647,469,986.06, compared to CNY 691,175,879.11 in the previous year, indicating a decline of 6.3%[27]. - The company reported a total cash outflow from financing activities of CNY 265,719,478.39, compared to CNY 188,911,308.03 in the previous year, indicating an increase of 40.6%[28]. - Cash and cash equivalents at the end of Q1 2022 were CNY 233,565,112.62, down from CNY 274,281,873.94 at the end of Q1 2021[28]. - The cash and cash equivalents decreased to CNY 253,874,088.24 from CNY 299,361,975.03 at the beginning of the year[18]. Assets and Liabilities - The total assets at the end of Q1 2022 were ¥1,627,394,738.32, a slight decrease of 0.62% from ¥1,637,617,535.07 at the end of the previous year[5]. - The total liabilities as of March 31, 2022, were CNY 750,940,418.22, down from CNY 793,088,893.48 at the start of the year[20]. - The company's non-current liabilities decreased to CNY 46,212,111.38 from CNY 52,048,370.07 at the beginning of the year[20]. - The equity attributable to shareholders increased by 3.61% to ¥785,800,449.03 from ¥758,397,541.67 at the end of the previous year[5]. - The company's retained earnings increased to CNY 446,548,767.31 from CNY 419,145,859.95 at the beginning of the year[20]. Operational Developments - The company is expanding its production capacity with a new green packaging intelligent manufacturing industrial park project in Xi'an, which includes a primary and secondary pharmaceutical packaging production center and a technology R&D center[13]. - The company has signed a construction project general contracting contract with China Construction Fourth Engineering Bureau for the new industrial park[13]. - The company has strengthened its collection of accounts receivable, contributing to the improved cash flow from operating activities despite a decline in revenue[8]. Research and Development - Research and development expenses amounted to CNY 16,502,638.89, a decrease of 32.1% from CNY 24,341,072.20 in Q1 2021[23]. Share Issuance - The company plans to issue up to 68,040,000 shares through a non-public offering, which will not exceed 27% of the total share capital before the issuance[14]. - The company received approval from the China Securities Regulatory Commission for the non-public offering on March 2, 2022[14].